Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qyuns Therapeutics CoHKSE:02509 -2.06%9 Days Inventory is 21.30 as of Dec. 2025, which is 0% below its 10-year median of 21.39. GuruFocus rates HKSE:02509 with a GF Score™ of 9/100. The stock has 5 warning signs investors should review. Among 637 Biotechnology companies, Qyuns Therapeutics Co ranks better than 93.56% on this metric.
The historical rank and industry rank for Qyuns Therapeutics Co's Days Inventory or its related term are showing as below:
HKSE:02509'
s Days Inventory Range Over the Past 10 Years
Min: 19.74 Med: 21.39 Max: 23.86
Current: 23.86
During the past 5 years, Qyuns Therapeutics Co's highest Days Inventory was 23.86. The lowest was 19.74. And the median was 21.39.
HKSE:02509's Days Inventory is ranked better than 93.56% of 637
companies
in the Biotechnology industry
Industry Median: 180.38
vs HKSE:02509: 23.86
Qyuns Therapeutics Co's Days Inventory
declined
from Dec. 2024 (21.88) to Dec. 2025 (21.30).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Qyuns Therapeutics Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 8.57.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qyuns Therapeutics Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.01.
Qyuns Therapeutics Co (HKSE:02509) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Qyuns Therapeutics Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qyuns Therapeutics Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Qyuns Therapeutics Co Days Inventory Related Terms
Qyuns Therapeutics Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Qyuns Therapeutics Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02509 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Qyuns Therapeutics Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qyuns Therapeutics Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Qyuns Therapeutics Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qyuns Therapeutics Co (HKSE:02509) has a Days Inventory of 21.30 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qyuns Therapeutics Co and its competitors. This is near median its historical median of 21.39. Over the past decade, Qyuns Therapeutics Co's Days Inventory has ranged from 19.74 to 23.86. According to the industry distribution chart, Qyuns Therapeutics Co ranks #41 out of 637 companies in the Biotechnology industry, placing it in the top 6.4%.
Is Qyuns Therapeutics Co's Days Inventory too high?
Qyuns Therapeutics Co's current Days Inventory of 21.30 is near median its 10-year median of 21.39. Over the past 10 years, this metric has ranged from a low of 19.74 to a high of 23.86. The Biotechnology industry median Days Inventory is 180.38. Qyuns Therapeutics Co's value of 21.30 is 88.2% below this industry median. Based on the distribution chart, Qyuns Therapeutics Co ranks #41 out of 637 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Qyuns Therapeutics Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Qyuns Therapeutics Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Qyuns Therapeutics Co ranks #41 out of 637 companies for Days Inventory. This places Qyuns Therapeutics Co in the top 6% of its industry — outperforming the majority of peers. The industry median Days Inventory is 180.38. Qyuns Therapeutics Co's value of 21.30 is 88.2% below this benchmark. Historically, Qyuns Therapeutics Co's own Days Inventory has ranged from 19.74 to 23.86 over the past decade. While the company's 10-year median is 21.39 vs. the industry median of 180.38, Qyuns Therapeutics Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 180.38, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qyuns Therapeutics Co's current Days Inventory of 21.30 is 88.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qyuns Therapeutics Co and its competitors. For the Biotechnology industry, the median Days Inventory is 180.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qyuns Therapeutics Co's current Days Inventory is 21.30, which is near median its own 10-year median of 21.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qyuns Therapeutics Co stock overvalued right now?
Qyuns Therapeutics Co (HKSE:02509) has a current Days Inventory of 21.30. The current Days Inventory is 21.30, which is near median its 10-year median of 21.39 and 88.2% below the Biotechnology industry median of 180.38. Qyuns Therapeutics Co's overall GF Score™ is 9/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Qyuns Therapeutics Co (HKSE:02509), the current Days Inventory is 21.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Qyuns Therapeutics Co Ltd is a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline. It has built a pipeline that covers the four disease areas in the field, including skin, rheumatic, respiratory, and digestive diseases. The group is principally engaged in the research and development, manufacturing, and commercialisation of biologic therapies for autoimmune and allergic diseases. Key revenue is generated from the PRC.
9GF Score
Get the complete analysis for HKSE:02509
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02509 has been successfully added to your 
